FR20C1026I1 - Ciclesonide pour le traitement de maladies des voies respiratoires chez les chevaux - Google Patents

Ciclesonide pour le traitement de maladies des voies respiratoires chez les chevaux

Info

Publication number
FR20C1026I1
FR20C1026I1 FR20C1026C FR20C1026C FR20C1026I1 FR 20C1026 I1 FR20C1026 I1 FR 20C1026I1 FR 20C1026 C FR20C1026 C FR 20C1026C FR 20C1026 C FR20C1026 C FR 20C1026C FR 20C1026 I1 FR20C1026 I1 FR 20C1026I1
Authority
FR
France
Prior art keywords
ciclesonide
horses
diseases
treatment
respiratory tract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR20C1026C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Vetmedica GmbH
Original Assignee
Boehringer Ingelheim Vetmedica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47552829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR20C1026(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmedica GmbH filed Critical Boehringer Ingelheim Vetmedica GmbH
Publication of FR20C1026I1 publication Critical patent/FR20C1026I1/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
FR20C1026C 2012-12-21 2020-06-26 Ciclesonide pour le traitement de maladies des voies respiratoires chez les chevaux Active FR20C1026I1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12199302 2012-12-21
EP13811924.3A EP2934479B1 (fr) 2012-12-21 2013-12-18 Ciclésonide pour le traitement de maladies des voies respiratoires chez les chevaux
PCT/EP2013/077265 WO2014096115A1 (fr) 2012-12-21 2013-12-18 Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux

Publications (1)

Publication Number Publication Date
FR20C1026I1 true FR20C1026I1 (fr) 2020-10-02

Family

ID=47552829

Family Applications (1)

Application Number Title Priority Date Filing Date
FR20C1026C Active FR20C1026I1 (fr) 2012-12-21 2020-06-26 Ciclesonide pour le traitement de maladies des voies respiratoires chez les chevaux

Country Status (24)

Country Link
US (4) US20140179651A1 (fr)
EP (1) EP2934479B1 (fr)
AR (1) AR094241A1 (fr)
AU (2) AU2013360691B2 (fr)
BR (2) BR112015010842B1 (fr)
CA (1) CA2888428C (fr)
CY (2) CY1121115T1 (fr)
DK (1) DK2934479T3 (fr)
ES (1) ES2693779T3 (fr)
FR (1) FR20C1026I1 (fr)
HR (1) HRP20181980T1 (fr)
HU (1) HUS2000020I1 (fr)
IN (1) IN2015DN02894A (fr)
LT (2) LT2934479T (fr)
MA (1) MA38169B2 (fr)
MX (1) MX368306B (fr)
NO (1) NO2020014I1 (fr)
NZ (1) NZ706573A (fr)
PL (1) PL2934479T3 (fr)
PT (1) PT2934479T (fr)
RS (1) RS57740B1 (fr)
SI (1) SI2934479T1 (fr)
WO (1) WO2014096115A1 (fr)
ZA (1) ZA201502288B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103781468A (zh) 2011-08-12 2014-05-07 勃林格殷格翰动物保健有限公司 治疗及预防猫科动物心脏衰竭的方法中所用的起搏电流(If)抑制剂
EP3473255B1 (fr) 2012-12-21 2022-01-12 Boehringer Ingelheim Vetmedica GmbH Formulation pharmaceutique comprenant du ciclésonide
RS57740B1 (sr) 2012-12-21 2018-12-31 Boehringer Ingelheim Vetmedica Gmbh Ciklezonid za lečenje oboljenja disajnih puteva kod konja
EP3157522B1 (fr) 2014-06-18 2019-09-04 Boehringer Ingelheim Vetmedica GmbH Antagonistes muscariniques et combinaisons de ceux-ci pour le traitement de maladies des voies respiratoires chez les chevaux
WO2018070819A1 (fr) * 2016-10-14 2018-04-19 제주대학교 산학협력단 Composition comprenant du ciclésonide destinée à inhiber la croissance de cellules souches cancéreuses
EP4087581A1 (fr) 2020-01-10 2022-11-16 Boehringer Ingelheim Vetmedica GmbH Ciclésonide pour améliorer la qualité de vie (qol) chez les équidés
AU2021314977A1 (en) 2020-07-31 2023-03-02 Chemo Research, S.L. Combination therapy for inhalation administration

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954049A (en) 1991-10-15 1999-09-21 Trudell Medical Limited Equine mask with MDI adapter
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
DE10050994A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10062712A1 (de) 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US6904908B2 (en) 2002-05-21 2005-06-14 Trudell Medical International Visual indicator for an aerosol medication delivery apparatus and system
DE10237739A1 (de) 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
AU2003272450A1 (en) 2002-09-13 2004-04-30 C. Steven Smith Novel composition and method for treatment of upper respiratory conditions
US20060293293A1 (en) * 2003-05-22 2006-12-28 Altana Pharma Ag Salmeterol and ciclesonide combination
US20050020692A1 (en) 2003-07-24 2005-01-27 Ciofalo Vincent B. Treatment of heaves
EP1670482B2 (fr) 2003-09-16 2022-06-29 Covis Pharma B.V. Utilisation de ciclesonide dans le traitement de maladies respiratoires
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
CA2563556C (fr) 2004-04-20 2013-01-29 Altana Pharma Ag Utilisation de ciclesonide pour le traitement des maladies respiratoires chez des patients fumeurs
CA2568834A1 (fr) 2004-06-29 2006-01-12 Boehringer Ingelheim International Gmbh Medicaments pour inhalation comprenant des steroides et un anticholinergique
DE102004056579A1 (de) 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
UY30542A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
UY30543A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
AU2010265187B2 (en) 2009-06-25 2015-05-14 Boehringer Ingelheim Vetmedica Gmbh Inhaler
US7829748B1 (en) 2009-09-21 2010-11-09 Honeywell International Inc. Process for the manufacture of 1,3,3,3-tetrafluoropropene
WO2014007767A1 (fr) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalateurs de poudre sèche comprenant un excipient autre que le lactose et un composant ternaire
EA201590019A1 (ru) 2012-07-05 2015-09-30 Арвен Айлак Санайи Ве Тиджарет А.С. Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы
US9539408B2 (en) 2012-10-31 2017-01-10 Trudell Medical International Nebulizer apparatus
EP3473255B1 (fr) 2012-12-21 2022-01-12 Boehringer Ingelheim Vetmedica GmbH Formulation pharmaceutique comprenant du ciclésonide
RS57740B1 (sr) 2012-12-21 2018-12-31 Boehringer Ingelheim Vetmedica Gmbh Ciklezonid za lečenje oboljenja disajnih puteva kod konja
AU2014310917B2 (en) 2013-08-20 2018-08-16 Boehringer Ingelheim Vetmedica Gmbh Inhaler
EP3632373B1 (fr) 2013-08-20 2023-08-09 Boehringer Ingelheim Vetmedica GmbH Inhalateur
EP3157522B1 (fr) 2014-06-18 2019-09-04 Boehringer Ingelheim Vetmedica GmbH Antagonistes muscariniques et combinaisons de ceux-ci pour le traitement de maladies des voies respiratoires chez les chevaux

Also Published As

Publication number Publication date
LTPA2020511I1 (lt) 2020-07-27
US20180153907A1 (en) 2018-06-07
ZA201502288B (en) 2019-09-25
HRP20181980T1 (hr) 2019-01-25
BR112015010842B1 (pt) 2021-03-30
PT2934479T (pt) 2018-12-20
MA38169A1 (fr) 2017-01-31
AU2018201642A1 (en) 2018-03-29
EP2934479B1 (fr) 2018-09-19
CA2888428A1 (fr) 2014-06-26
AU2013360691A1 (en) 2015-04-16
MA38169B2 (fr) 2021-08-31
MX368306B (es) 2019-09-27
CA2888428C (fr) 2021-07-13
CY1121115T1 (el) 2019-12-11
DK2934479T3 (en) 2018-11-05
NO2020014I1 (no) 2020-06-12
IN2015DN02894A (fr) 2015-09-11
US20150313918A1 (en) 2015-11-05
BR112015010842A8 (pt) 2019-10-01
US20170079988A1 (en) 2017-03-23
WO2014096115A1 (fr) 2014-06-26
CY2020015I1 (el) 2020-11-25
PL2934479T3 (pl) 2019-02-28
MX2015007947A (es) 2015-10-08
BR112015010842A2 (pt) 2017-07-11
SI2934479T1 (sl) 2019-01-31
BR122016029247A2 (pt) 2019-08-20
CY2020015I2 (el) 2021-03-12
HUS2000020I1 (hu) 2020-07-28
RS57740B1 (sr) 2018-12-31
ES2693779T3 (es) 2018-12-13
LT2934479T (lt) 2018-12-27
AU2018201642B2 (en) 2019-01-31
US10258634B2 (en) 2019-04-16
US20140179651A1 (en) 2014-06-26
US9918995B2 (en) 2018-03-20
AU2013360691B2 (en) 2018-03-08
AR094241A1 (es) 2015-07-22
EP2934479A1 (fr) 2015-10-28
US10441597B2 (en) 2019-10-15
NZ706573A (en) 2019-11-29

Similar Documents

Publication Publication Date Title
FR20C1026I1 (fr) Ciclesonide pour le traitement de maladies des voies respiratoires chez les chevaux
GB2492487B (en) Cannabinoids for use in the treatment of neurodegenerative diseases or disorders
EA201991484A1 (ru) Лекарственные формы энзалутамида
IL239368A0 (en) Sparing–ppar thiazolidinediones and combinations for the treatment of neurodegenerative diseases of the nervous system
EP2911664A4 (fr) Polythérapies pour le traitement de la maladie d'alzheimer et des troubles associés
IL236920B (en) Ophthalmic compositions and their use for treatment of eye diseases and disorders in animals
FR2948687B1 (fr) Utilisation de microarn pour le traitement de pathologies respiratoires chroniques
GB201511770D0 (en) Novel pharmaceutical formulationsand their use in the treatment of periodontal disease
IL268757A (en) Pharmaceutical preparations containing 7-(H1-imidazol-4-ylmethyl)-8,7,6,5-tetrahydroquinoline for the treatment of skin diseases and conditions
MA39950A (fr) Dérivé de 2-acylaminothiazole pour le traitement des maladies des voies urinaires et de la vessie
IL237730B (en) Treatment of mild and moderate Alzheimer's disease
SI2874600T1 (sl) Farmacevtski sestavek za zdravljenje hripavosti ali bolečin v grlu
HUE038580T2 (hu) Hatóanyag bejuttató rendszer neurológiai rendellenességek kezelésében, vagy diagnózisában való felhasználásra
PL2774991T3 (pl) System dostarczania leków do stosowania w leczeniu lub diagnostyce zaburzeń neurologicznych
IL239078A0 (en) Protein for use in the treatment of eye diseases
FR2992219B1 (fr) Composition pour le traitement de l'hypocalcemie chez les ruminants
FR2992315B1 (fr) Derives utiles dans le traitement de maladies du systeme nerveux central
FR2976807B1 (fr) Composition pharmaceutique pour le traitement de la dependance chez l'etre humain
ZA201306759B (en) Compounds for use in imaging,diagnosing and/or treatment of diseases of the central nervous system
FR2976493B1 (fr) Electrode combinee pour le traitement de l'hyperhidrose
FR2985907B1 (fr) Composition pharmaceutique pour le traitement des dysfonctions erectiles
FR2974182B1 (fr) Diagnostic et traitement de l'angioedeme
HUP1300454A2 (hu) Daganatos betegségek gyógyítására és megelõzésére alkalmas gyógyászati készítmények, és eljárás azok elõállítására